The results of radiosurgical management of 72 middle fossa meningiomas
- PMID: 8333310
- DOI: 10.1007/BF01446988
The results of radiosurgical management of 72 middle fossa meningiomas
Abstract
Of 812 patients with intracranial tumours treated by radiosurgery during the period 1984-1990, 129 had meningiomas. Of these latter, 72 had middle fossa meningiomas. Patients with meningiomas treated by us since March 1990 are not included in this report since we established the investigative principle of a minimum of 30 months follow-up. Seventeen of the 72 patients were treated after incomplete surgical resection, and 21 for tumour regrowth. In 34 patients, radiosurgery was the primary treatment. The tumour volume was calculated by the ellipsoid method. It ranged from 0.588-76.346 ml. Radiosurgery was performed using the non-invasive stereotactic fixation head device (Greitz-Bergström) adapted to the Fixster frame, and dynamic irradiation performed with the linear accelerator, using especially designed collimators. The total tumour dose for each patient ranged from 15-45 Gy. The minimum follow-up was 2 1/2 years and the maximum 8 years. In 50 patients there was tumour shrinkage ranging from 24-91% of the initial tumour volume. Shrinkage was associated with central tumour necrosis in 11 of these 50 patients. In 18 patients the tumour volume remained stable. In 2 patients there was tumour progression and in 2 there was regrowth after initial reduction of tumour volume. There were no significant treatment complications. Radiosurgery is preferable to re-operation in recurrent meningiomas and indicated after incomplete surgical removal. In high risk patients, as well as in "unresectable" meningiomas, it is an obvious alternative to microsurgery.
Similar articles
-
Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.Clin Neurol Neurosurg. 2017 Feb;153:93-101. doi: 10.1016/j.clineuro.2016.12.014. Epub 2016 Dec 29. Clin Neurol Neurosurg. 2017. PMID: 28081463
-
Analysis the causes of radiosurgical failure in intracranial meningiomas treated with radiosurgery.Clin Neurol Neurosurg. 2017 Mar;154:51-58. doi: 10.1016/j.clineuro.2017.01.013. Epub 2017 Jan 20. Clin Neurol Neurosurg. 2017. PMID: 28129632
-
Stereotactic LINAC radiosurgery for the treatment of typical intracranial meningiomas. Efficacy and safety after a follow-up of over 12 years.Strahlenther Onkol. 2015 Dec;191(12):921-7. doi: 10.1007/s00066-015-0880-9. Epub 2015 Aug 8. Strahlenther Onkol. 2015. PMID: 26253788
-
Long term experience of gamma knife radiosurgery for benign skull base meningiomas.J Neurol Neurosurg Psychiatry. 2005 Oct;76(10):1425-30. doi: 10.1136/jnnp.2004.049213. J Neurol Neurosurg Psychiatry. 2005. PMID: 16170090 Free PMC article. Review.
-
[Significance of radiosurgery for the treatment of meningiomas].Cas Lek Cesk. 2011;150(4-5):250-3. Cas Lek Cesk. 2011. PMID: 21634204 Review. Czech.
Cited by
-
Tumour response and morphological changes of acoustic neurinomas after radiosurgery.Acta Neurochir (Wien). 1995;133(3-4):157-63. doi: 10.1007/BF01420067. Acta Neurochir (Wien). 1995. PMID: 8748759
-
A prospective study of cavernous sinus surgery for meningiomas and resultant common ophthalmic complications (an American Ophthalmological Society thesis).Trans Am Ophthalmol Soc. 2007;105:392-447. Trans Am Ophthalmol Soc. 2007. PMID: 18427624 Free PMC article.
-
Linear accelerator-based stereotactic radiosurgery of intracranial meningiomas: results of the first 5 years of clinical practice.Neurosurg Rev. 2011 Jan;34(1):87-99. doi: 10.1007/s10143-010-0288-z. Epub 2010 Oct 9. Neurosurg Rev. 2011. PMID: 20936421
-
European Society for Stereotactic and Functional Neurosurgery. Abstracts selected for presentation at the 11th Congress. Antalya, Turkey, September 24-27, 1994.Acta Neurochir (Wien). 1994;129(3-4):209-51. Acta Neurochir (Wien). 1994. PMID: 7847166 No abstract available.
-
[Stereotactic one-time irradiation (radiosurgery). The methods, indications and results].Strahlenther Onkol. 1999 Feb;175(2):47-56. doi: 10.1007/BF02753842. Strahlenther Onkol. 1999. PMID: 10065138 Review. German.